T. Habara

发表

Quality of life for patients with schizophrenia in a Japanese psychiatric hospital

S. Terada, S. Kuroda, H. Ishizu, 2006, Psychiatry Research.

Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogs.

K. Sasahara, T. Nitanai, T. Habara, 1981, Journal of pharmaceutical sciences.

Effects of subchronic lithium chloride treatment on G-protein subunits (Golf, Ggamma7) and adenylyl cyclase expressed specifically in the rat striatum.

H. Ujike, T. Hamamura, S. Kuroda, 2001, European journal of pharmacology.

M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain.

T. Hamamura, S. Kuroda, K. Ohashi, 2001, European journal of pharmacology.

Efficacy of second-generation antipsychotics in patients at ultra-high risk and those with first-episode or multi-episode schizophrenia

T. Takeda, Soichiro Sato, K. Washida, 2013, Neuropsychiatric disease and treatment.

Contrasting Fos expression induced by acute reboxetine and fluoxetine in the rat forebrain: neuroanatomical substrates for the antidepressant effect

T. Hamamura, S. Kuroda, S. Miyata, 2004, Psychopharmacology.

Dosage form design for improvement of bioavailability of levodopa II: bioavailability of marketed levodopa preparations in dogs and parkinsonian patients.

K. Sasahara, T. Nitanai, T. Habara, 1980, Journal of pharmaceutical sciences.

Dosage form design for improvement of bioavailability of levodopa III: Influence of dose on pharmacokinetic behavior of levodopa in dogs and Parkinsonian patients.

K. Sasahara, T. Nitanai, T. Habara, 1980, Journal of pharmaceutical sciences.

Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.

T. Hamamura, S. Kuroda, S. Miyata, 2004, Life sciences.

Dosage form design for improvement of bioavailability of levodopa V: Absorption and metabolism of levodopa in intestinal segments of dogs.

K. Sasahara, T. Nitanai, T. Habara, 1981, Journal of pharmaceutical sciences.